Proteomic Analysis of Plasma in a Phase 2 Clinical Trial in Alzheimer&#39;s Patients to Identify Pharmacodynamic Biomarkers of the S2R Modulator CT1812

Elayta (CT1812) - Cognition Therap

https://www.ctad-alzheimer.com/files/files/CTAD%20ABSTRACT%202023%20oct%2024_compressed.pdf

Britney Lizama 1; Eunah Cho 1; Duc Duong 2; Kiran Pandey 3; Claire Williams 1; Anthony Caggiano 1; Nicholas Seyfried2; Valentina Di Caro1; Mary Hamby1

Jul 4, 2023